Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development
Anna KruczynskiResearch Center for Experimental Oncology, Pierre Fabre Research Institute, Parc Technologique du Canal, 3 rue des Satellites, BP 94244, 31432 Toulouse, Cedex 04, France. [email protected]Maura PoliMario Negri Institute for Pharmacological Research, Via Gavazzeni, 11, 24125 Bergamo, ItalyRomina DossiMario Negri Institute for Pharmacological Research, Via Gavazzeni, 11, 24125 Bergamo, ItalyEric ChazottesResearch Center for Experimental Oncology, Pierre Fabre Research Institute, Parc Technologique du Canal, 3 rue des Satellites, BP 94244, 31432 Toulouse, Cedex 04, FranceGéraldine BerrichonResearch Center for Experimental Oncology, Pierre Fabre Research Institute, Parc Technologique du Canal, 3 rue des Satellites, BP 94244, 31432 Toulouse, Cedex 04, FranceChristel RicomeResearch Center for Experimental Oncology, Pierre Fabre Research Institute, Parc Technologique du Canal, 3 rue des Satellites, BP 94244, 31432 Toulouse, Cedex 04, FranceRaffaella GiavazziMario Negri Institute for Pharmacological Research, Via Gavazzeni, 11, 24125 Bergamo, ItalyBridget T. HillResearch Center for Experimental Oncology, Pierre Fabre Research Institute, Parc Technologique du Canal, 3 rue des Satellites, BP 94244, 31432 Toulouse, Cedex 04, FranceGiulia TarabolettiMario Negri Institute for Pharmacological Research, Via Gavazzeni, 11, 24125 Bergamo, Italy
2006en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0